Sunderby Sjukhus Medicinkliniken
About Sunderby Sjukhus Medicinkliniken
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
2
Clinical Trials at Sunderby Sjukhus Medicinkliniken
During the past decade, Sunderby Sjukhus Medicinkliniken conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
2017-11-07
2025-12-22
Active, not recruiting
390
A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
2018-04-17
2024-04-05
Active, not recruiting
211
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sunderby Sjukhus Medicinkliniken"
#1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Sunderby Sjukhus Medicinkliniken
According to Clinical.Site data, the most researched conditions in "Sunderby Sjukhus Medicinkliniken" are
"Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials) and "Smoldering Multiple Myeloma" (1 trials). Many other conditions were trialed in "Sunderby Sjukhus Medicinkliniken" in a lesser frequency.
Clinical Trials Intervention Types at Sunderby Sjukhus Medicinkliniken
Most popular intervention types in "Sunderby Sjukhus Medicinkliniken" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Chlorambucil" (1 trials), "Daratumumab SC: daratumumab + rHuPH20" (1 trials), "Ibrutinib" (1 trials), "Ibrutinib (as Subsequent Therapy)" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sunderby Sjukhus Medicinkliniken
The vast majority of trials in "Sunderby Sjukhus Medicinkliniken" are
2 trials for "All" genders.
Clinical Trials Status at Sunderby Sjukhus Medicinkliniken
Currently, there are NaN active trials in "Sunderby Sjukhus Medicinkliniken".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sunderby Sjukhus Medicinkliniken,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sunderby Sjukhus Medicinkliniken, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".